Stay updated with breaking news from Epitopes Dses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Argus Research, an independent investment research firm, has launched Argus Equity Report coverage on ProMIS Neurosciences, Inc. (TSX:PMN)...
ProMIS Neurosciences Offers Perspectives on Recent Progress in the Alzheimer’s/Amyloid Field Two positive events in January support PMN310 “best in class” positioning TORONTO and CAMBRIDGE, Mass., Feb. 02, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today its perspectives on recent progress in the Alzheimer’s field. Two important events occurred in January 2021, bo...
(2) Two positive events in January support PMN310 "best in class" positioning TORONTO and CAMBRIDGE, Mass., Feb. 02, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today its perspectives on recent progress in the Alzheimer's field. Two important events occurred in January 2021, both of which we consider very positive for the Alzheimer's field, for the updated amyloid hypothes...
ProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Strategic Priorities for 2021 TORONTO and CAMBRIDGE, Mass., Jan. 12, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today an outline of its strategic priorities and action plan for 2021. The priorities for 2021 fall into four key areas: Near term focus on rare neurodegenerative diseases, especially ALS Use of proprieta...